文献速递血管炎

聚焦NETs:探索NETosis标志物用于追踪IgA血管炎疾病活动度

NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

一项纵向研究纳入33例儿童IgA血管炎(IgAV)患者和26例健康对照,检测活动期与非活动期血清和尿液中NETosis标志物。活动期患者血清cf-DNA显著高于对照组和非活动期组;尿cit-H3在活动期和非活动期均高于对照;血清cf-DNA阈值935 ng/ml的敏感度为93%、特异度为72%。

要点

  • 活动期IgAV患者血清cf-DNA显著高于健康对照和非活动期患者(P=0.04)。
  • 尿cit-H3在活动期和非活动期均高于健康对照(P=0.01和P=0.03)。
  • 血清cf-DNA阈值935 ng/ml区分活动期患者与健康对照的敏感度93%、特异度72%。

核心结论

  • 血清cf-DNA升高和尿cit-H3升高提示NETosis可能参与IgAV疾病活动,这些标志物有潜力作为疾病监测的指标。
  • 作者认为需要进一步研究以建立IgAV中NETosis标志物评估的标准化方案。

研究设计与样本

  • 纵向研究,纳入33例儿童IgAV患者和26例健康对照。
  • 在健康对照及患者活动期和非活动期采集血液和尿液样本。
  • 采用ELISA试剂盒检测NETosis标志物,包括游离DNA(cf-DNA)、中性粒细胞弹性蛋白酶、MPO和瓜氨酸化组蛋白H3(cit-H3)。

主要发现

  • 患者组与对照组在性别和年龄上无显著差异。
  • 活动期患者组血清cf-DNA水平显著高于对照组(P=0.04)和非活动期患者组(P=0.04)。
  • 活动期患者尿液MPO水平显著低于对照组(P=0.009)。
  • 尿cit-H3水平在活动期(P=0.01)和非活动期(P=0.03)均高于对照组。
  • 血清cf-DNA阈值935 ng/ml区分活动期患者与健康对照的敏感度为93%、特异度为72%。

关键数值与推荐

  • 血清cf-DNA阈值935 ng/ml:敏感度93%(正确识别93%的活动期患者),特异度72%(正确识别72%的健康对照)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 作者认为需要进一步研究以建立IgAV中NETosis标志物评估的标准化方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The role of neutrophil extracellular traps (NETs) in IgA vasculitis (IgAV) pathogenesis is emerging, with NETosis-associated markers potentially linked to disease activity. This study aimed to explore the relationship between NETosis biomarkers and IgAV disease phases. METHODS: A longitudinal study involving 33 paediatric IgAV patients and 26 healthy controls was conducted. Blood and urine samples were collected from healthy controls and patients during active and inactive disease phases. NETosis markers, including cell-free DNA (cf-DNA), neutrophil elastase, MPO and citrullinated histone H3 (cit-H3) were measured using ELISA kits. Statistical analyses were conducted to compare differences for NETosis markers between groups and to evaluate correlations among variables using appropriate statistical tests. RESULTS: There was no significant difference in gender and age between the patient and control groups. The serum cf-DNA level was significantly higher in the active patient group compared with the control and inactive patient groups (P = 0.04; P = 0.04, respectively). In urine, MPO levels were significantly lower in the active phase of patients than controls (P = 0.009), while cit-H3 levels were higher in both active and inactive phases compared with controls (P = 0.01 and P = 0.03, respectively). A cf-DNA threshold of 935 ng/ml was identified, which achieved a sensitivity of 93% (correctly identifying 93% of active patients) and a specificity of 72% (correctly identifying 72% of healthy controls). CONCLUSION: Elevated serum cf-DNA and urine cit-H3 suggest a potential role for NETosis in IgAV activity, highlighting these markers as potential indicators for disease monitoring. Further studies are warranted to establish standardized protocols for NETosis marker assessment in IgAV.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Guliyeva V, Demirkan FG, Bektaş E, et al. NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis. Rheumatology (Oxford). 2025. PMID: 40397989. doi:10.1093/rheumatology/keaf272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。